Using confocal microscopy we show that cellular retinoic acid-binding protein type I (CRABP I), expressed in several embryonic cell types, displays a compartmentalized subcellular distribution. The protein was excluded from the nucleus in some cells, while in others it accumulated in the nucleus. In the rat cerebellar cell line ST15A, which expresses CRABP I, the protein was found in the cytoplasm with a prominent nuclear exclusion. Addition of retinoic acid to embryos in vivo and to ST15 A cells in vitro did not affect the localization of the protein. Localization of CRABP I and CRABP I fused to a nuclear localization signal expressed in transfected cells, suggested that cell-specific factors may regulate nuclear import of CRABP I. The potential role of a CRABP I-controlled nuclear import of retinoic acid is discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0925-4773(96)00554-0DOI Listing

Publication Analysis

Top Keywords

nuclear import
12
cellular retinoic
8
retinoic acid-binding
8
acid-binding protein
8
protein type
8
retinoic acid
8
crabp
6
nuclear
5
protein
5
import cellular
4

Similar Publications

Quantitative imaging of loop extruders rebuilding interphase genome architecture after mitosis.

J Cell Biol

March 2025

Cell Biology and Biophysics Unit, European Molecular Biology Laboratory (EMBL) , Heidelberg, Germany.

How cells establish the interphase genome organization after mitosis is incompletely understood. Using quantitative and super-resolution microscopy, we show that the transition from a Condensin to a Cohesin-based genome organization occurs dynamically over 2 h. While a significant fraction of Condensins remains chromatin-bound until early G1, Cohesin-STAG1 and its boundary factor CTCF are rapidly imported into daughter nuclei in telophase, immediately bind chromosomes as individual complexes, and are sufficient to build the first interphase TAD structures.

View Article and Find Full Text PDF

Background: A growing amount of data has implicated the various roles of nuclear genes involved in mitochondrial function, and mitochondrial genes, on risk for Alzheimer's disease (AD) and AD neuroimaging biomarkers. To date, no studies have investigated the relationship of mitochondrial haplogroups or the APOE and TOMM40 genes on brain glucose metabolism, a sensitive early marker of metabolic decline and possible mitochondrial dysfunction in AD.

Method: We analyzed regional standard uptake value ratio (SUVR) differences in F-fluorodeoxyglucose positron emission tomography (FDG-PET) using SPM12 and CAT12 software between nondemented (ND, n=69), mild cognitively impaired (MCI, n=19) and AD (n=18) groups in a sample of individuals from the University of Kansas Alzheimer's Disease Research Center Cohort, controlling for age, sex, and education.

View Article and Find Full Text PDF

Background: A growing amount of data has implicated the various roles of nuclear genes involved in mitochondrial function, and mitochondrial genes, on risk for Alzheimer's disease (AD) and AD neuroimaging biomarkers. To date, no studies have investigated the relationship of mitochondrial haplogroups or the APOE and TOMM40 genes on brain glucose metabolism, a sensitive early marker of metabolic decline and possible mitochondrial dysfunction in AD.

Method: We analyzed regional standard uptake value ratio (SUVR) differences in 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) using SPM12 and CAT12 software between nondemented (ND, n = 69), mild cognitively impaired (MCI, n = 19) and AD (n = 18) groups in a sample of individuals from the University of Kansas Alzheimer's Disease Research Center Cohort, controlling for age, sex, and education.

View Article and Find Full Text PDF

Colon cancer remains a significant health burden globally, necessitating deeper investigation. Identification and targeting of prognostic markers can significantly improve the current therapeutic approaches for colon cancer. The differential nuclear transport (import and export) of cellular proteins, plays an important role in tumor progression.

View Article and Find Full Text PDF

Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids.

Molecules

December 2024

Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.

Therapeutic nucleic acids (TNAs) including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) have emerged as promising treatment strategies for a wide variety of diseases, offering the potential to modulate gene expression with a high degree of specificity. These small, synthetic nucleic acid-like molecules provide unique advantages over traditional pharmacological agents, including the ability to target previously "undruggable" genes. Despite this promise, several biological barriers severely limit their clinical efficacy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!